Mar 01, 2022
Mar 01, 2023
For Pharmacists, MLI will accept your completed evaluation form for up to 30 days and will report your participation to the NABP only if you provide your NABP e-Profile number and date of birth. Within 6 weeks, view your participation record at the NABP website: https://nabp.pharmacy/
Ms. Hall is a Registered Dietitian and Certified Diabetes Educator. She earned Bachelor’s and Master’s degrees in Nutrition and Dietetics from The University of Incarnate Word, San Antonio, Texas. An entrepreneur, she is sole proprietor of DANS-Diabetes and Nutrition Services, LLC.
Ms. Hall has more than 20 years of experience providing nutrition counseling, diabetes management, and meal planning in the acute, sub-acute, long-term care and public health settings. She applies her expertise to empower her clients, patients, and health-care professionals to self-manage their medical conditions through motivational interviewing, behavior modification, diet. and physical activity.
Dr. Patel is an Adjunct Associate Professor of Pharmacy Practice at Massachusetts College of Pharmacy in Boston. He was an endocrine clinical pharmacy specialist at the VA Boston Healthcare System for 12 years. He has recently transitioned to a Cardiometabolic Concierge Clinic.
Dr. Patel currently serves on the American Association of Diabetes Educators’ Technology Committee, the American Diabetes Association’s Overcoming Therapeutic Inertia Initiative, the CDC’s Diabetes Prevention Serious Game Steering Committee, and as a diabetes technology expert for the American Medical Association. Dr. Patel has been published in numerous peer-reviewed journals and delivered numerous presentations and lectures on diabetes and diabetes technology.
Dr. Shubrook is a board-certified family physician and a fellowship-trained diabetologist. He is a Professor in the Primary Care Department and Director of Clinical Research at Touro University California. He is also an Associate Editor of Clinical Diabetes and Director of Diabetes Services for Solano County Family Health Services.
Dr Shubrook’s research interests include prevention of and early intervention for type 2 diabetes. His clinical interests including training the primary care workforce to help patients improve management of their diabetes.
Ms. Whitmire is a Nurse Practitioner in the Endocrinology Department at Southwest Medical Associates in Las Vegas, Nevada. She graduated Summa Cum Laude from Arizona State University with a Bachelor’s Degree in Health Science and earned her Nurse Practitioner Degree from Duke University.
Ms. Whitmire is Board Certified in Advanced Diabetes Management and is a Certified Diabetes Care and Education Specialist. She has spent her entire nursing career caring for patients with diabetes and has a passion for improving outcomes for this population.
While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.
Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.
In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc., the Endocrine Society and National Committee for Quality Assurance (NCQA). Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Consultant and/or Advisor for 89Bio, Akero, Altimmune, Axcella Health, Becton Dickenson, Boehringer Ingelheim, Carmot Therapeutics, Echosens, Eli Lilly, Gilead, Merck, Metacrine, Novo Nordisk, Pfizer, Sanofi
Grant/Research Support from Akero, Abbvie, AstraZeneca, Boehringer Ingelheim, BMS, Eli Lilly, Intercept, Janssen, Madrigal, Merck, Metacrine, NorthSea, Novartis, Novo Nordisk, Oramed, Pfizer, Poxil, Sanofi
Speakers Bureau participant with Merck, Novo Nordisk, Sanofi
Consultant and/or Advisor for Abbott, Amarin, Astra Zeneca, Bayer, Boehringer Ingelheim, Dexcom, Insulet, Lilly, Merck, Novo Nordisk, Sanofi, Xeris, Zealand
Speakers Bureau participant with Abbott, Amarin, Astra Zeneca, Bayer, Boehringer Ingelheim, Dexcom, Insulet, Lilly, Merck, Novo Nordisk, Sanofi, Xeris, Zealand
Consultant and/or Advisor for Astra Zeneca, Bayer, Eli Lilly
All of the relevant financial relationships of individuals for this activity have been mitigated.
The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of Medical Learning Institute, Inc. or any of its partners, providers, and/or supporters.